Challenges of diabetes in elderly TB patients
- PMID: 36400521
- PMCID: PMC9613800
- DOI: 10.1016/j.ijtb.2022.10.017
Challenges of diabetes in elderly TB patients
Abstract
Diabetes mellitus (DM) and tuberculosis (TB) are worldwide health burdens post-COVID-19. TB is the second-leading cause of death by a single infectious microbe. There is much evidence around the world about the responsibility of TB-DM co-morbidity. Both TB and DM prevalence is high in low- and middle-income countries. Especially the elderly with diabetes are more prone to TB infection due to compromised immune systems. Diabetic patients are three times as likely to develop tuberculosis as non-diabetic patients. DM interferes with the status of TB and leads to undesirable outcomes in the treatment of TB. This may later lead to the development of multidrug-resistant tuberculosis (MDR-TB). The coexistence of TB and DM leads to a high mortality rate and therefore becomes an enormous challenge for the medical field. This viewpoint includes the most current information about TB and DM, disease complications, treatment strategies, challenges to be faced in disease management and the importance of TB-DM bidirectional screening in older adults, which helps in early detection and better treatment programme.
Keywords: Ageing population; Diabetes mellitus; Multi-resistant tuberculosis (MDR-TB); Mycobacterium tuberculosis; Prevalence; Tuberculosis.
Copyright © 2022 Tuberculosis Association of India. Published by Elsevier B.V. All rights reserved.
Similar articles
-
Risk Factors for Multidrug-resistant Tuberculosis.Acta Med Indones. 2018 Jan;50(1):1-2. Acta Med Indones. 2018. PMID: 29686169
-
Impact of diabetes on treatment outcomes and long-term survival in multidrug-resistant tuberculosis.Respiration. 2013;86(6):472-8. doi: 10.1159/000348374. Epub 2013 May 8. Respiration. 2013. PMID: 23689646
-
Navigating the dual burden of diabetes mellitus and tuberculosis: A comprehensive review of clinical and public health strategies.Indian J Tuberc. 2025 Apr;72(2):253-258. doi: 10.1016/j.ijtb.2025.03.011. Epub 2025 Mar 19. Indian J Tuberc. 2025. PMID: 40518222 Review.
-
Diabetes mellitus comorbidity in patients enrolled in tuberculosis drug efficacy trials around the world: A systematic review.Br J Clin Pharmacol. 2019 Jul;85(7):1407-1417. doi: 10.1111/bcp.13935. Epub 2019 May 17. Br J Clin Pharmacol. 2019. PMID: 30908689 Free PMC article.
-
Clinical characteristics, drug resistance, and treatment outcomes among tuberculosis patients with diabetes in Peru.Int J Infect Dis. 2013 Jun;17(6):e404-12. doi: 10.1016/j.ijid.2012.12.029. Epub 2013 Feb 22. Int J Infect Dis. 2013. PMID: 23434400 Free PMC article.
Cited by
-
Tuberculosis and COVID-19 in the elderly: factors driving a higher burden of disease.Front Immunol. 2023 Sep 27;14:1250198. doi: 10.3389/fimmu.2023.1250198. eCollection 2023. Front Immunol. 2023. PMID: 37841265 Free PMC article. Review.
-
Analysis of drug resistance in pulmonary tuberculosis patients with positive sputum tuberculosis culture in Northeast China.Front Pharmacol. 2023 Sep 25;14:1263726. doi: 10.3389/fphar.2023.1263726. eCollection 2023. Front Pharmacol. 2023. PMID: 37818197 Free PMC article.
References
-
- World Health Organization. Global tuberculosis report 2021. [Updated 2021 Oct 114]. Available from: https://www.who.int/news-room/fact-sheets/detail/tuberculosis. (Accessed July 26, 2022).
-
- Indian Diabetes Atlas Tenth edition 2021. [Updated 2021 Dec 12]. Available from: https://idf.org/aboutdiabetes/what-is-diabetes/facts-figures.html. (Accessed July 27, 2022).
-
- World Health Organization. Diabetes: fact sheet number 312. [Updated 2013 Mar 1]. Available from: http://www.who.int/mediacentre/factsheets/fs312/en/index.html (Accessed July 26, 2022).
-
- World Health Organization . World Health Organization; 2011. A Collaborative Framework for Care and Control of Tuberculosis and Diabetes. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical